Camber Capital Management’s AngioDynamics ANGO Stock Holding History

Camber Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-540,362	Closed	-$8.28M	–	34
2020 Q4	$8.28M	Buy	540,362 +519,486	+2,488%	+$6.59M	0.29%	31
2020 Q3	$252K	Buy	+20,876	New	+$198K	0.01%	35
2016 Q2	–	Sell	-243,183	Closed	-$2.99M	–	50
2016 Q1	$2.99M	Hold	243,183	–	–	0.18%	44
2015 Q4	$2.95M	Sell	243,183 -15,000	-6%	-$185K	0.19%	40
2015 Q3	$3.4M	Sell	258,183 -477,200	-65%	-$7.2M	0.29%	40
2015 Q2	$12.1M	Buy	735,383 +6,900	+0.9%	+$115K	0.82%	31
2015 Q1	$13M	Buy	728,483 +363,853	+100%	+$6.76M	0.93%	27
2014 Q4	$6.93M	Hold	364,630	–	–	0.46%	35
2014 Q3	$5M	Sell	364,630 -19,000	-5%	-$271K	0.47%	34
2014 Q2	$6.26M	Sell	383,630 -28,300	-7%	-$410K	0.41%	38
2014 Q1	$6.49M	Sell	411,930 -588,070	-59%	-$9.58M	0.51%	37
2013 Q4	$17.2M	Sell	1,000,000 -327,500	-25%	-$5.04M	1.52%	22
2013 Q3	$17.5M	Hold	1,327,500	–	–	1.84%	20
2013 Q2	$15M	Buy	+1,327,500	New	+$14.1M	1.54%	20

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Camber Capital Management's ANGO Position: Q1 2021 in Review

Camber Capital Management sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 540,362 shares — an estimated $8.28M sold.

Camber Capital Management first reported a position in ANGO in Q2 2013 and held it in 14 quarters. The position peaked at $17.5M in Q3 2013. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

Camber Capital Management reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
Camber Capital Management sold 540,362 AngioDynamics shares in Q1 2021, an estimated $8.28M.
Camber Capital Management first reported a position in AngioDynamics in Q2 2013 and held it in 14 quarters.
Camber Capital Management's AngioDynamics position peaked at $17.5M in Q3 2013.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on Camber Capital Management's 13F filing for Q1 2021, filed 17 May 2021.